Koers Staidson (Beijing) BioPharmaceuticals Co., Ltd.
Aandelen
300204
CNE100001237
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,3 CNY | -2,17% | +11,50% | -37,99% |
Omzet 2022 | 549 mln. 75,77 mln. 70,86 mln. | Omzet 2023 | 364 mln. 50,26 mln. 47,01 mln. | Marktkapitalisatie | 4,85 mld. 670 mln. 627 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -197 mln. -27,19 mln. -25,43 mln. | Nettowinst (verlies) 2023 | -399 mln. -55,07 mln. -51,5 mln. | EV/omzet 2022 | 11,2 x |
Nettoliquiditeiten 2022 | 259 mln. 35,76 mln. 33,45 mln. | Nettoliquiditeiten 2023 | 44,23 mln. 6,1 mln. 5,71 mln. | EV/omzet 2023 | 13,2 x |
K/w-verhouding 2022 |
-33,2
x | K/w-verhouding 2023 |
-12,1
x | Werknemers | 555 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 25,45% |
1 dag | -2,17% | ||
1 week | +11,50% | ||
Lopende maand | -6,80% | ||
1 maand | -7,62% | ||
3 maanden | -27,84% | ||
6 maanden | -31,89% | ||
Lopend jaar | -37,99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chao Wang
CEO | Chief Executive Officer | 42 | 01-07-11 |
Shi Cheng Li
DFI | Director of Finance/CFO | 42 | 26-08-20 |
Zhi Wen Zhou
PSD | President | 59 | 01-01-02 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hong Shan Zhang
CHM | Chairman | 60 | 01-01-02 |
Zhi Wen Zhou
CHM | Chairman | 59 | 01-01-02 |
Tao Li
BRD | Director/Board Member | 61 | 01-01-08 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +2,14% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 6,3 | -2,17% | 13 344 480 |
25-04-24 | 6,44 | +8,60% | 20 493 430 |
24-04-24 | 5,93 | +0,68% | 3 745 100 |
23-04-24 | 5,89 | +2,43% | 5 902 655 |
22-04-24 | 5,75 | +1,77% | 4 771 600 |
slotkoers Shenzhen S.E., 26 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-37,99% | 415 mln. | |
-4,66% | 86,13 mld. | |
+1,32% | 39,82 mld. | |
-19,27% | 30,42 mld. | |
+57,86% | 25,23 mld. | |
-16,09% | 15,35 mld. | |
-9,14% | 11,95 mld. | |
-17,69% | 11,6 mld. | |
-43,00% | 11,51 mld. | |
+5,24% | 8,71 mld. |